title: Pim-1 kinase antagonizes aspects of myocardial hypertrophy and compensation to pathological pressure overload.
abstract: Pim-1 kinase exerts potent cardioprotective effects in the myocardium downstream of AKT, but the participation of Pim-1 in cardiac hypertrophy requires investigation. Cardiac-specific expression of Pim-1 (Pim-WT) or the dominant-negative mutant of Pim-1 (Pim-DN) in transgenic mice together with adenoviral-mediated overexpression of these Pim-1 constructs was used to delineate the role of Pim-1 in hypertrophy. Transgenic overexpression of Pim-1 protects mice from pressure-overload-induced hypertrophy relative to wild-type controls as evidenced by improved hemodynamic function, decreased apoptosis, increases in antihypertrophic proteins, smaller myocyte size, and inhibition of hypertrophic signaling after challenge. Similarly, Pim-1 overexpression in neonatal rat cardiomyocyte cultures inhibits hypertrophy induced by endothelin-1. On the cellular level, hearts of Pim-WT mice show enhanced incorporation of BrdU into myocytes and a hypercellular phenotype compared to wild-type controls after hypertrophic challenge. In comparison, transgenic overexpression of Pim-DN leads to dilated cardiomyopathy characterized by increased apoptosis, fibrosis, and severely depressed cardiac function. Furthermore, overexpression of Pim-DN leads to reduced contractility as evidenced by reduced Ca(2+) transient amplitude and decreased percentage of cell shortening in isolated myocytes. These data support a pivotal role for Pim-1 in modulation of hypertrophy by impacting responses on molecular, cellular, and organ levels.
authors.affiliation: San Diego State Heart Institute, San Diego State University, 5500 Campanile Drive, San Diego, CA 92182, USA.
authors.forename: John A
authors.initials: JA
authors.lastname: Muraski
authors.forename: Kimberlee M
authors.initials: KM
authors.lastname: Fischer
authors.forename: Weitao
authors.initials: W
authors.lastname: Wu
authors.forename: Christopher T
authors.initials: CT
authors.lastname: Cottage
authors.forename: Pearl
authors.initials: P
authors.lastname: Quijada
authors.forename: Matt
authors.initials: M
authors.lastname: Mason
authors.forename: Shabana
authors.initials: S
authors.lastname: Din
authors.forename: Natalie
authors.initials: N
authors.lastname: Gude
authors.forename: Roberto
authors.initials: R
authors.lastname: Alvarez
authors.forename: Marcello
authors.initials: M
authors.lastname: Rota
authors.forename: Jan
authors.initials: J
authors.lastname: Kajstura
authors.forename: Zeping
authors.initials: Z
authors.lastname: Wang
authors.forename: Erik
authors.initials: E
authors.lastname: Schaefer
authors.forename: Xiongen
authors.initials: X
authors.lastname: Chen
authors.forename: Scott
authors.initials: S
authors.lastname: MacDonnel
authors.forename: Nancy
authors.initials: N
authors.lastname: Magnuson
authors.forename: Stephen R
authors.initials: SR
authors.lastname: Houser
authors.forename: Piero
authors.initials: P
authors.lastname: Anversa
authors.forename: Mark A
authors.initials: MA
authors.lastname: Sussman
mesh_terms: D000818:Animals; D030801:Animals, Genetically Modified; D001011:Aorta / Q000201:enzymology; D017209:Apoptosis; D006332:Cardiomegaly / Q000139:chemically induced / Q000201:enzymology* / Q000473:pathology* / Q000503:physiopathology; D002478:Cells, Cultured; D019332:Endothelin-1 / Q000494:pharmacology; D005355:Fibrosis; D009119:Muscle Contraction; D051573:Proto-Oncogene Proteins c-pim-1 / Q000037:antagonists & inhibitors* / Q000235:genetics / Q000378:metabolism*; D051381:Rats
chemical_list: D019332:Endothelin-1; D051573:Proto-Oncogene Proteins c-pim-1
references.citation: Am J Physiol Cell Physiol. 2007 Jun;292(6):C2269-75
references.pmid: 17287366
references.citation: Circ Res. 2005 Dec 9;97(12):1332-41
references.pmid: 16293788
references.citation: Circ Res. 2004 Apr 16;94(7):884-91
references.pmid: 14988230
references.citation: Biochim Biophys Acta. 2002 Oct 10;1584(2-3):73-80
references.pmid: 12385889
references.citation: J Clin Invest. 2005 Oct;115(10):2716-30
references.pmid: 16200208
references.citation: Cardiovasc Toxicol. 2003;3(3):191-206
references.pmid: 14555786
references.citation: Annu Rev Physiol. 2004;66:29-48
references.pmid: 14977395
references.citation: J Biol Chem. 2003 Nov 28;278(48):47622-8
references.pmid: 13129932
references.citation: Circulation. 1995 Oct 15;92(8):2306-17
references.pmid: 7554216
references.citation: Circ Res. 2003 Dec 12;93(12):1179-92
references.pmid: 14670833
references.citation: Genes Dev. 2003 Aug 1;17(15):1841-54
references.pmid: 12869584
references.citation: Circ J. 2004 Mar;68(3):247-53
references.pmid: 14993781
references.citation: Proc Natl Acad Sci U S A. 2002 Sep 17;99(19):12333-8
references.pmid: 12237475
references.citation: Proc Natl Acad Sci U S A. 2006 Aug 8;103(32):11946-51
references.pmid: 16882732
references.citation: Am J Physiol Heart Circ Physiol. 2004 Nov;287(5):H2164-72
references.pmid: 15256372
references.citation: Nat Med. 2007 Dec;13(12):1467-75
references.pmid: 18037896
references.citation: Oncogene. 2008 Aug 14;27(35):4809-19
references.pmid: 18438430
references.citation: Nat Med. 2002 Aug;8(8):864-71
references.pmid: 12134142
references.citation: Ann N Y Acad Sci. 2004 May;1015:250-60
references.pmid: 15201165
references.citation: Herz. 2002 Nov;27(7):662-8
references.pmid: 12439637
references.citation: Mol Cancer Res. 2007 Sep;5(9):909-22
references.pmid: 17855660
references.citation: Chromosoma. 2002 Jul;111(2):80-95
references.pmid: 12111331
references.citation: Circ Res. 2006 Aug 18;99(4):381-8
references.pmid: 16840722
references.citation: Blood. 2005 Jun 1;105(11):4477-83
references.pmid: 15705789
references.citation: Stem Cells. 2008 May;26(5):1315-24
references.pmid: 18308948
references.citation: J Vet Sci. 2001 Dec;2(3):167-79
references.pmid: 12441685
references.citation: Circ Res. 2002 May 31;90(10):1055-63
references.pmid: 12039794